OpenFilings

Aurinia Pharmaceuticals Inc.

Form10-K

Report Period2022-12-31

Date Filed2023-02-28

Time Filed06:10:25

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-10.20 FORM OF INDUCEMENT RESTRICTED STOCK UNIT AWARD
EX-10.21 FORM OF RESTRICTED STOCK UNIT AWARD
EX-21.1 LIST OF SUBSIDIARIES
EX-23.1 CONSENT
EX-31.1 CERTIFICATION
EX-31.2 CERTIFICATION
EX-32.1 CERTIFICATION SOX
EX-32.2 CERTIFICATION SOX
Filing on SEC Edgar